Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate
German pharma group finds no unexpected side effects during trial, including at higher doses
German group aims to join companies whose fortunes have been transformed by weight loss treatments
US judge dismisses almost 2,500 lawsuits alleging links between heartburn medication and cancer
From astrophysicists to entrepreneurs, technology leads drugmakers to seek new skills
Veterinary pharma group has pet project in emerging markets
An unsettling revision to an agreed deal
UK-listed pharma group renegotiates price for US generics arm of Boehringer Ingelheim
It becomes the latest Magic Circle firm to change leadership
Targeted transactions can help companies focus on the right market
Swapping animal health for consumer products looks sensible rather than transformational for Sanofi
Agreement with Boehringer Ingelheim involves exchange for Merial animal health unit
Sanofi may sell Merial — and trigger a flurry of deals
‘Unprecedented’ success of Jardiance to cut heart-related deaths prompts analysts to ramp up forecasts
FTSE 100 ended 0.4% higher, up 24.77 points at 6,083.31 in volatile trading
